Parkinson’s disease research

Exploring new options for Parkinson’s disease

An estimated 7 to 10 million people worldwide have Parkinson’s disease1. Although there have been many advances in the management of the condition, therapies focus on treating the symptoms, whereas Biogen is focused on slowing down or delaying the disease’s progression.

Parkinson’s is a life-changing condition and those affected currently face an uncertain and unpredictable future. Our vision is to discover, develop and deliver life-changing therapies that address unmet medical needs to improve the lives of patients with movement disorders, and their caregivers, around the world.

  1. Parkinson’s News Today https://parkinsonsnewstoday.com/parkinsons-disease-statistics/ Accessed 10 May 2019

Our Parkinson’s disease clinical trials

Spark

A phase 2 clinical trial for people with Parkinson’s disease

Status
Start Date
Condition
Estimated
enrollment
Age Range
Phase
Study Type

Status
Start Date
Condition
Estimated
enrollment
Age Range
Phase
Study Type

Status
Start Date
Condition
Estimated
enrollment
Age Range
Phase
Study Type